<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>89</volume><submitter>Feng X</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Primary retroperitoneal neoplasms (PRNs) are a diverse group of tumors that pose significant diagnostic challenges. Currently, no multicenter-validated diagnostic model exists for multiple PRN types based on computed tomography (CT) images. This study aimed to develop and validate an end-to-end deep learning model, REMIND (REtroperitoneal neoplasMs artificial-INtelligence Diagnosis), for the accurate diagnosis and segmentation of PRNs using enhanced CT images.&lt;h4>Methods&lt;/h4>Patients from 12 Chinese centers between January 2012 and June 2024 were involved in this study. The dataset comprised patients with histologically confirmed PRNs, including seven types of PRNs: dedifferentiated liposarcoma, well-differentiated liposarcoma, leiomyosarcoma, ganglioneuroma, lymphoma, s</pubmed_abstract><journal>EClinicalMedicine</journal><pagination>103498</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12508580</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>End-to-end deep learning model for the diagnosis and segmentation of primary retroperitoneal neoplasm: a multicenter cohort study.</pubmed_title><pmcid>PMC12508580</pmcid><pubmed_authors>Meng T</pubmed_authors><pubmed_authors>Hao Q</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Gao J</pubmed_authors><pubmed_authors>Deng L</pubmed_authors><pubmed_authors>Zhao T</pubmed_authors><pubmed_authors>Feng C</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Shao C</pubmed_authors><pubmed_authors>Kang F</pubmed_authors><pubmed_authors>Xu B</pubmed_authors><pubmed_authors>Zhuang A</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Chen R</pubmed_authors><pubmed_authors>Song Z</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Yang L</pubmed_authors><pubmed_authors>Gu Y</pubmed_authors><pubmed_authors>Feng X</pubmed_authors><pubmed_authors>He H</pubmed_authors><pubmed_authors>Cui J</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Liang B</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Yang P</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>End-to-end deep learning model for the diagnosis and segmentation of primary retroperitoneal neoplasm: a multicenter cohort study.</name><description>&lt;h4>Background&lt;/h4>Primary retroperitoneal neoplasms (PRNs) are a diverse group of tumors that pose significant diagnostic challenges. Currently, no multicenter-validated diagnostic model exists for multiple PRN types based on computed tomography (CT) images. This study aimed to develop and validate an end-to-end deep learning model, REMIND (REtroperitoneal neoplasMs artificial-INtelligence Diagnosis), for the accurate diagnosis and segmentation of PRNs using enhanced CT images.&lt;h4>Methods&lt;/h4>Patients from 12 Chinese centers between January 2012 and June 2024 were involved in this study. The dataset comprised patients with histologically confirmed PRNs, including seven types of PRNs: dedifferentiated liposarcoma, well-differentiated liposarcoma, leiomyosarcoma, ganglioneuroma, lymphoma, s</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-04T10:12:13.541Z</modification><creation>2026-05-08T03:10:27.328Z</creation></dates><accession>S-EPMC12508580</accession><cross_references><pubmed>41079030</pubmed><doi>10.1016/j.eclinm.2025.103498</doi></cross_references></HashMap>